Pages that link to "Q44359882"
Jump to navigation
Jump to search
The following pages link to Paraoxonase (PON1) deficiency is associated with increased macrophage oxidative stress: studies in PON1-knockout mice (Q44359882):
Displaying 50 items.
- Paraoxonase 1 (PON1) enhances HDL-mediated macrophage cholesterol efflux via the ABCA1 transporter in association with increased HDL binding to the cells: a possible role for lysophosphatidylcholine (Q24295161) (← links)
- The Role of Oxidative Damage in the Pathogenesis and Progression of Alzheimer's Disease and Vascular Dementia (Q26795415) (← links)
- PON1 and Mediterranean Diet (Q26824686) (← links)
- Modulation of paraoxonases during infectious diseases and its potential impact on atherosclerosis (Q27004131) (← links)
- Paired measurements of paraoxonase 1 and serum amyloid A as useful disease markers (Q27006749) (← links)
- Modulation of paraoxonase 1 and 3 expression after moderate exercise training in the rat (Q28566625) (← links)
- Serum paraoxonase and arylesterase activities in patients with lung cancer in a Turkish population (Q33278805) (← links)
- Studies on HDL associated enzymes under experimental hypercholesterolemia: possible modulation on selenium supplementation (Q33587302) (← links)
- Decreased paraoxonase-1 activity is associated with alterations of high-density lipoprotein particles in chronic liver impairment (Q33878870) (← links)
- The assessment of carotid intima media thickness and serum paraoxonase-1 activity in Helicobacter pylori positive subjects (Q34114349) (← links)
- Relationship of paraoxonase 1 (PON1) gene polymorphisms and functional activity with systemic oxidative stress and cardiovascular risk (Q34457337) (← links)
- Participation of ATP7A in macrophage mediated oxidation of LDL. (Q34559932) (← links)
- Paraoxonase1 genetic polymorphisms in a mixed ancestry African population (Q34590668) (← links)
- Serum paraoxonase-1 as biomarker for improved diagnosis of fatty liver in dairy cows (Q34665004) (← links)
- Lead exposure is associated with decreased serum paraoxonase 1 (PON1) activity and genotypes (Q35001794) (← links)
- Effects on transcriptional regulation and lipid droplet characteristics in the liver of female juvenile pigs after early postnatal feed restriction and refeeding are dependent on birth weight. (Q35048017) (← links)
- Interactions between paraoxonase 1 genetic polymorphisms and smoking and their effects on oxidative stress and lung cancer risk in a Korean population (Q35151639) (← links)
- PON3 knockout mice are susceptible to obesity, gallstone formation, and atherosclerosis (Q35410647) (← links)
- Paraoxonase-3 is depleted from the high-density lipoproteins of autoimmune disease patients with subclinical atherosclerosis (Q35615662) (← links)
- Regulation of hepatic paraoxonase-1 expression (Q35882841) (← links)
- PON-1 Activity and Plasma 8-Isoprostane Concentration in Patients with Angiographically Proven Coronary Artery Disease (Q36366974) (← links)
- The concentration of thiobarbituric acid reactive substances (TBARS) and paraoxonase activity in blood of patients with osteoarthrosis after endoprosthesis implantation (Q36576648) (← links)
- Relationship of human paraoxonase-1 serum activity and genotype with atherosclerosis in individuals from the Deep South (Q36755341) (← links)
- Pomegranate for your cardiovascular health (Q36919245) (← links)
- There is no relationship between Paraoxonase serum level activity in women with endometriosis and the stage of the disease: an observational study. (Q36996548) (← links)
- Abundance of plasma antioxidant proteins confers tolerance to acute hypobaric hypoxia exposure (Q37202581) (← links)
- New roles of HDL in inflammation and hematopoiesis (Q37314961) (← links)
- Role of PON in anoxia-reoxygenation injury: a Drosophila melanogaster transgenic model (Q37439214) (← links)
- Acetylcholinesterase/paraoxonase genotype and expression predict anxiety scores in Health, Risk Factors, Exercise Training, and Genetics study (Q37681855) (← links)
- Molecular biology of atherosclerosis (Q38125279) (← links)
- Atherogenesis: hyperhomocysteinemia interactions with LDL, macrophage function, paraoxonase 1, and exercise (Q38724228) (← links)
- A review of paraoxonase 1 properties and diagnostic applications (Q38812792) (← links)
- Assessment of the relationship between serum paraoxonase activity and epicardial adipose tissue in hemodialysis patients (Q38853533) (← links)
- Injection of paraoxonase 1 (PON1) to mice stimulates their HDL and macrophage antiatherogenicity (Q39429336) (← links)
- Cholesterol reduction and macrophage function: role of paraoxonases (Q39457518) (← links)
- The antioxidant HDL-associated paraoxonase-1 (PON1) attenuates diabetes development and stimulates β-cell insulin release (Q39485791) (← links)
- Paraoxonase 1 (PON1) inhibits monocyte-to-macrophage differentiation (Q39499014) (← links)
- Formaldehyde induces neurotoxicity to PC12 cells involving inhibition of paraoxonase-1 expression and activity (Q39603847) (← links)
- Paraoxonase lactonase activity (PON-HTLase), asymmetric dimethylarginine (ADMA) and platelet activating factor-acetylhydrolase (PAF-AH) activity in non-obese women with PCOS. (Q39614144) (← links)
- The catalytic histidine dyad of high density lipoprotein-associated serum paraoxonase-1 (PON1) is essential for PON1-mediated inhibition of low density lipoprotein oxidation and stimulation of macrophage cholesterol efflux (Q40331033) (← links)
- Serum paraoxonase activity, total thiols levels, and oxidative status in patients with acute brucellosis. (Q41468366) (← links)
- Paraoxonase is reduced in patients with growth hormone deficiency: A novel risk factor for atherosclerosis (Q41854438) (← links)
- Beneficial effect of oleoylated lipids on paraoxonase 1: protection against oxidative inactivation and stabilization (Q42157061) (← links)
- Effect of cyclosporine-a on paraoxonase activity in wistar rats (Q42727210) (← links)
- PON1 status evaluation in patients with chronic arterial occlusion of lower limbs due to atherosclerosis obliterans (Q43107935) (← links)
- Effect of atorvastatin on paraoxonase1 (PON1) and oxidative status (Q43244728) (← links)
- Semen traits and seminal plasma biochemical parameters in white leghorn layer breeders. (Q43948651) (← links)
- Methylmercury-induced inhibition of paraoxonase-1 (PON1)-implications for cardiovascular risk (Q44382504) (← links)
- Decreased Macrophage Paraoxonase 2 Expression in Patients With Hypercholesterolemia Is the Result of Their Increased Cellular Cholesterol Content: Effect of Atorvastatin Therapy (Q44639042) (← links)
- Oxidative inactivation of paraoxonase1, an antioxidant protein and its effect on antioxidant action (Q44749869) (← links)